Leaflet INVIRASE 200mg capsules
Indicated for: HIV-1 infection
Route of administration: oral
Substance: saquinavir (protease inhibitor)
ATC: J05AE01 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Saquinavir is a protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection. It works by inhibiting the HIV protease enzyme, which is essential for processing viral proteins and forming mature viral particles, thereby reducing viral replication in the body.
Saquinavir is administered orally, usually in combination with other antiretroviral medications, as part of highly active antiretroviral therapy (HAART). It is used to reduce viral load, increase CD4 cell counts, and prevent the progression of the disease to acquired immunodeficiency syndrome (AIDS).
Common side effects include nausea, diarrhea, abdominal pain, and fatigue. In rare cases, severe adverse reactions such as hepatotoxicity, hyperglycemia, or allergic reactions may occur. Regular monitoring of liver function and metabolic parameters is essential.
Saquinavir is an important component of antiretroviral therapy, contributing to the effective management of HIV infection and improving patients' quality of life.
General data about INVIRASE 200mg
- Substance: saquinavir
- Date of last drug list: 01-01-2014
- Commercial code: W05508001
- Concentration: 200mg
- Pharmaceutical form: capsules
- Quantity: 270
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for saquinavir
Concentrations available for saquinavir
- 200mg
- 500mg